Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home / News

News

New book summarizes state of eHealth applications

New book summarizes state of eHealth applications

by ellen.degraffenreid last modified May 01, 2012 08:49 AM

UNC’s Seth Noar examines intersection of technology and health

New book summarizes state of eHealth applications - Read More…

Armistead receives Mentored Clinical Scientist Development Award

Armistead receives Mentored Clinical Scientist Development Award

by ellen.degraffenreid last modified Apr 24, 2012 04:36 PM

Paul Armistead, MD, PhD, has received a grant of more than $396,000 from the National Heart, Lung and Blood Institute (part of the National Institutes of Health) to study leukemia stem cell-associated minor histocompatibility antigens.

Armistead receives Mentored Clinical Scientist Development Award - Read More…

UNC junior’s research honored at American Association for Cancer Research meeting

UNC junior’s research honored at American Association for Cancer Research meeting

by ellen.degraffenreid last modified Apr 26, 2012 08:41 AM

UNC junior Molly DeCristo attended her first international scientific meeting, but not just as a participant. The American Association for Cancer Research (AACR) honored her poster with a rosette, judging it as “highly rated,” among the top 2.5 percent of those submitted.

UNC junior’s research honored at American Association for Cancer Research meeting - Read More…

Joyce Wilson: On Trips of a Lifetime, Planned and Unplanned

by ellen.degraffenreid last modified Apr 20, 2012 11:35 AM

A Wayne County woman doesn’t let cancer, its treatment or its recurrence get in the way of her plans to attend her oldest granddaughter’s high school graduation or her own 45th high school reunion.

Joyce Wilson: On Trips of a Lifetime, Planned and Unplanned - Read More…

Intensity Modulated Radiation Therapy optimal for localized prostate cancer

by ellen.degraffenreid last modified Apr 19, 2012 09:01 AM

Chapel Hill - A treatment for localized prostate cancer known as Intensity Modulated Radiation Therapy (IMRT) is better than conventional conformal radiation therapy (CRT) for reducing certain side effects and preventing cancer recurrence, according to a study published in the April 18, 2012 issue of the Journal of the American Medical Association. In 2012, approximately 241,740 American men will be diagnosed with prostate cancer.

Intensity Modulated Radiation Therapy optimal for localized prostate cancer - Read More…

International panel recommends new model for breast cancer care

by ellen.degraffenreid last modified Apr 23, 2012 08:21 AM

CHAPEL HILL, N.C. - As the number of breast cancer survivors increases, now estimated at 2.8 million, more will be living with the chronic effects of cancer treatments or with advanced disease.

International panel recommends new model for breast cancer care - Read More…

Coghill receives grant to study graft versus host disease

Coghill receives grant to study graft versus host disease

by ellen.degraffenreid last modified Apr 19, 2012 08:59 AM

James Coghill, MD, has received a grant of more than $529,000 from the National Heart, Lung and Blood Institute (part of the National Institutes of Health) to study a promising target for new therapies to combat graft versus host disease, a serious complication of treatment for many blood cancers.

Coghill receives grant to study graft versus host disease - Read More…

UNC scientists describe protein that protects against colon cancer

by ellen.degraffenreid last modified May 03, 2012 11:26 AM

Chapel Hill - A family of proteins is yielding new information about how it contributes to the development of gastrointestinal disease and cancer. A team of UNC scientists reports that in pre-clinical models, the absence of a protein called NLRP12 significantly increases susceptibility to colitis-associated colon cancer.

UNC scientists describe protein that protects against colon cancer - Read More…

Three-dimensional RNA modeling opens scientific doors

by maryruth.helms last modified Apr 17, 2012 10:05 AM

Chapel Hill, NC – In a paper published today in the journal Nature Methods, a team from the University of North Carolina at Chapel Hill demonstrates a simple, cost-effective technique for three-dimensional RNA structure prediction that will help scientists understand the structures, and ultimately the functions, of the RNA molecules that dictate almost every aspect of human cell behavior. When cell behavior goes wrong, diseases – including cancer and metabolic disorders – can be the result.

Three-dimensional RNA modeling opens scientific doors - Read More…

Study recommends national standards for tobacco use treatment

Study recommends national standards for tobacco use treatment

by maryruth.helms last modified Apr 16, 2012 12:00 PM

National Cancer Institute-designated cancer centers should lead the way

Study recommends national standards for tobacco use treatment - Read More…

UNC scientists describe protein that protects against colon cancer

by maryruth.helms last modified Apr 20, 2012 11:32 AM

Chapel Hill - A family of proteins is yielding new information about how it contributes to the development of gastrointestinal disease and cancer. A team of UNC scientists reports that in pre-clinical models, the absence of a protein called NLRP12 significantly increases susceptibility to colitis-associated colon cancer.

UNC scientists describe protein that protects against colon cancer - Read More…

Ten minutes could save your life: FREE Head & Neck Cancer Screenings

by maryruth.helms last modified Apr 12, 2012 02:27 PM

UNC Health Care will offer free screenings during Oral, Head and Neck Cancer Awareness Week, on Wednesday, April 25, from 1 - 4 p.m. in the Ear, Nose, & Throat Clinic on the ground floor of the N.C. Neurosciences Hospital.

Ten minutes could save your life: FREE Head & Neck Cancer Screenings - Read More…

Kinase test may yield big gains for drug-resistant cancers

by maryruth.helms last modified Apr 23, 2012 02:59 PM

Chapel Hill, NC – In a paper published today in the journal Cell, a team from the University of North Carolina at Chapel Hill unveils the first broad-based test for activation of protein kinases “en masse”, enabling measurement of the mechanism behind drug-resistant cancer and rational prediction of successful combination therapies.

Kinase test may yield big gains for drug-resistant cancers - Read More…

Gene switches do more than flip “on” or “off”

Gene switches do more than flip “on” or “off”

by maryruth.helms last modified Nov 02, 2012 09:46 AM

Chapel Hill - Anyone who’s tried a weekend home improvement project knows that to do a job right, you’ve got to have the right tools. For cells, these “tools” are proteins encoded by genes.

Gene switches do more than flip “on” or “off” - Read More…

Dr. Nancy DeMore and UNC colleagues present triple-negative breast cancer finding at national meeting

Dr. Nancy DeMore and UNC colleagues present triple-negative breast cancer finding at national meeting

by maryruth.helms last modified Apr 11, 2012 01:50 PM

Nancy DeMore, MD, and colleagues presented an abstract at the recent Society of Surgical Oncology 65th annual cancer symposium held in Orlando, Florida in March. Dr. DeMore is an associate professor of surgery and a member of UNC Lineberger.

Dr. Nancy DeMore and UNC colleagues present triple-negative breast cancer finding at national meeting - Read More…

UNC’s Neuro-oncology program recognizes Ependymoma Awareness Day on April 19th

UNC’s Neuro-oncology program recognizes Ependymoma Awareness Day on April 19th

by maryruth.helms last modified May 16, 2012 09:35 AM

UNC Cancer Care’s neuro-oncology program will recognize Ependymoma Awareness Day on April 19th, as part of the program’s overall efforts to increase public awareness of this rare tumor and the need for clinical studies to improve early diagnosis, standardize treatment and improve the health status of those living with this disease.

UNC’s Neuro-oncology program recognizes Ependymoma Awareness Day on April 19th - Read More…

Evans quoted in The News & Observer, Scientific American Blog

Evans quoted in The News & Observer, Scientific American Blog

by maryruth.helms last modified Apr 03, 2012 03:39 PM

James P. Evans, MD, PhD, Bryson Distinguished Professor of Genetics and Medicine, is quoted in recent articles in The News & Observer and the Scientific American blog.

Evans quoted in The News & Observer, Scientific American Blog - Read More…

Clinical trial of experimental drug targeting mutation in thyroid cancer shows clinical benefit

Clinical trial of experimental drug targeting mutation in thyroid cancer shows clinical benefit

by maryruth.helms last modified Apr 02, 2012 04:42 PM

Chapel Hill - In a clinical trial of an experimental drug to treat thyroid cancer, UNC and six other institutions report the first evidence in this tumor that targeting therapy to an oncogene documented to be present in the patient receiving therapy may be associated with clinical benefit.

Clinical trial of experimental drug targeting mutation in thyroid cancer shows clinical benefit - Read More…

Sharpless, Zanation honored as Health Care Heroes

Sharpless, Zanation honored as Health Care Heroes

by maryruth.helms last modified Apr 10, 2012 01:17 PM

UNC Lineberger faculty members Ned Sharpless, MD, and Adam Zanation, MD, were honored for their achievements by Triangle Business Journal as 2012 Health Care Heroes.

Sharpless, Zanation honored as Health Care Heroes - Read More…